TAp73 suppresses tumor angiogenesis through repression of proangiogenic cytokines and HIF-1α activity

被引:43
作者
Stantic, Marina [1 ]
Sakil, Habib A. M. [1 ]
Zirath, Hanna [1 ]
Fang, Trixy [1 ]
Sanz, Gema [1 ]
Fernandez-Woodbridge, Alejandro [1 ]
Marin, Ana [1 ]
Susanto, Evelyn [1 ]
Mak, Tak W. [2 ]
Henriksson, Marie Arsenian [1 ]
Wilhelm, Margareta T. [1 ]
机构
[1] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden
[2] Univ Hlth Network, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 2C1, Canada
基金
瑞典研究理事会;
关键词
p73; angiogenesis; HIF-1; alpha; tumor microenvironment; vascular permeability; GENE-EXPRESSION; IN-VIVO; ENDOTHELIAL-CELLS; POOR-PROGNOSIS; LUNG-CANCER; P73; DELTA-NP73; GROWTH; TRANSFORMATION; JUNCTIONS;
D O I
10.1073/pnas.1421697112
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The p53-family member TAp73 is known to function as a tumor suppressor and regulates genomic integrity, cellular proliferation, and apoptosis; however, its role in tumor angiogenesis is poorly understood. Here we demonstrate that TAp73 regulates tumor angiogenesis through repression of proangiogenic and proinflammatory cytokines. Importantly, loss of TAp73 results in highly vascularized tumors, as well as an increase in vessel permeability resulting from disruption of vascular endothelial-cadherin junctions between endothelial cells. In contrast, loss of the oncogenic p73 isoform Delta Np73 leads to reduced blood vessel formation in tumors. Furthermore, we show that up-regulated Delta Np73 levels are associated with increased angiogenesis in human breast cancer and that inhibition of TAp73 results in an accumulation of HIF-1 alpha and up-regulation of HIF-1 Delta target genes. Taken together, our data demonstrate that loss of TAp73 or Delta Np73 up-regulation activates the angiogenic switch that stimulates tumor growth and progression.
引用
收藏
页码:220 / 225
页数:6
相关论文
共 32 条
[1]   THE C-MYC ONCOGENE DRIVEN BY IMMUNOGLOBULIN ENHANCERS INDUCES LYMPHOID MALIGNANCY IN TRANSGENIC MICE [J].
ADAMS, JM ;
HARRIS, AW ;
PINKERT, CA ;
CORCORAN, LM ;
ALEXANDER, WS ;
CORY, S ;
PALMITER, RD ;
BRINSTER, RL .
NATURE, 1985, 318 (6046) :533-538
[2]   Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors [J].
Amin, DN ;
Hida, K ;
Bielenberg, DR ;
Klagsbrun, M .
CANCER RESEARCH, 2006, 66 (04) :2173-2180
[3]   Vascular Permeability and Drug Delivery in Cancers [J].
Azzi, Sandy ;
Hebda, Jagoda K. ;
Gavard, Julie .
FRONTIERS IN ONCOLOGY, 2013, 3
[4]   p73 poses a barrier to malignant transformation by limiting anchorage-independent growth [J].
Beitzinger, Michaela ;
Hofmann, Lars ;
Oswald, Claudia ;
Beinoraviciute-Kellner, Rasa ;
Sauer, Markus ;
Griesmann, Heidi ;
Bretz, Anne Catherine ;
Burek, Christof ;
Rosenwald, Andreas ;
Stiewe, Thorsten .
EMBO JOURNAL, 2008, 27 (05) :792-803
[5]   Vascular endothelial growth factor C induces angiogenesis in vivo [J].
Cao, YH ;
Linden, P ;
Farnebo, J ;
Cao, RH ;
Eriksson, A ;
Kumar, V ;
Qi, JH ;
Claesson-Welsh, L ;
Alitalo, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (24) :14389-14394
[6]   Gene expression of WWOX, FHIT and p73 in acute lymphoblastic leukemia [J].
Chen, Xu ;
Zhang, Hui ;
Li, Ping ;
Yang, Zheng ;
Qin, Lingyan ;
Mo, Wuning .
ONCOLOGY LETTERS, 2013, 6 (04) :963-969
[7]   ΔTAp73 upregulation correlates with poor prognosis in human tumors:: Putative in vivo network involving p73 isoforms, p53, and E2F-1 [J].
Domínguez, G ;
García, JM ;
Peña, C ;
Silva, J ;
García, V ;
Martínez, L ;
Maximiano, C ;
Gómez, ME ;
Rivera, JA ;
García-Andrade, C ;
Bonilla, F .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (05) :805-815
[8]   Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition -: The role of HIF-1α, HIF-2α, and other pathways [J].
Elvidge, Gareth P. ;
Glenny, Louisa ;
Appelhoff, Rebecca J. ;
Ratcliffe, Peter J. ;
Ragoussis, Jiannis ;
Gleadle, Jonathan M. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (22) :15215-15226
[9]   Human ΔNp73 regulates a dominant negative feedback loop for TAp73 and p53 [J].
Grob, TJ ;
Novak, U ;
Maisse, C ;
Barcaroli, D ;
Lüthi, AU ;
Pirnia, F ;
Hügli, B ;
Graber, HU ;
De Laurenzi, V ;
Fey, MF ;
Melino, G ;
Tobler, A .
CELL DEATH AND DIFFERENTIATION, 2001, 8 (12) :1213-1223
[10]   p73 overexpression and angiogenesis in human colorectal carcinoma [J].
Guan, M ;
Peng, HX ;
Yu, B ;
Lu, Y .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (05) :215-220